aluates Reports

$ 0.0

Automative

Global Non-infectious Macular Edema Treatment Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-31H5794

Global Non infectious Macular Edema Treatment Market Insights and Forecast to 2028

BUY CHAPTERS

Global Non-infectious Macular Edema Treatment Market Insights, Forecast to 2030

Code: QYRE-Auto-31H5794

Report

December 2024

Pages:105

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Allergan plc

Amgen Inc

Pfizer Inc

Novartis

F. Hoffman-La Roche

AbbVie

Bayer

Valeant Pharmaceuticals

Alimera Sciences

Clearside Biomedical

Non-infectious Macular Edema Treatment Market Size

The global Non-infectious Macular Edema Treatment market is projected to grow from US$ 11440 million in 2024 to US$ 15240 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.9% during the forecast period.

Non-infectious Macular Edema Treatment Market

Non-infectious Macular Edema Treatment refers to the treatment of Non-infectious Macular Edema by drugs or therapies such as anti-VEGF therapy, corticosteroids, immunosuppressive agents, and biological agents. The macula is a region of the center of the retina. Macular edema is the accumulation of fluid in the macula that causes the macula to swell and thicken, thereby distorting vision.

Market Analysis and Insights: Global Non-infectious Macular Edema Treatment Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Non-infectious Macular Edema Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Non-infectious Macular Edema Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Non-infectious Macular Edema Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-infectious Macular Edema Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Non-infectious Macular Edema Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Non-infectious Macular Edema Treatment revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Non-infectious Macular Edema Treatment Market Report

Report Metric	Details
Report Name	Non-infectious Macular Edema Treatment Market
Accounted market size in 2024	US$ 11440 million
Forecasted market size in 2030	US$ 15240 million
CAGR	4.9
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Anti-VEGF Therapy Corticosteroid Immune Inhibitor Biological Preparation Other
Segment by Application	Retail Pharmacy Hospital Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Allergan, Amgen, Pfizer, Novartis AG, F. Hoffman-La Roche, AbbVie, Bayer AG, Valeant Pharmaceuticals, Alimera Sciences, Clearside Biomedical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Non-infectious Macular Edema Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-infectious Macular Edema Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-infectious Macular Edema Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Non-infectious Macular Edema Treatment Market growing?

Ans: The Non-infectious Macular Edema Treatment Market witnessing a CAGR of 4.9 during the forecast period 2025-2030.

What is the Non-infectious Macular Edema Treatment Market size in 2030?

Ans: The Non-infectious Macular Edema Treatment Market size in 2030 will be US$ 15240 million.

Who are the main players in the Non-infectious Macular Edema Treatment Market report?

Ans: The main players in the Non-infectious Macular Edema Treatment Market are Allergan, Amgen, Pfizer, Novartis AG, F. Hoffman-La Roche, AbbVie, Bayer AG, Valeant Pharmaceuticals, Alimera Sciences, Clearside Biomedical

What are the Application segmentation covered in the Non-infectious Macular Edema Treatment Market report?

Ans: The Applications covered in the Non-infectious Macular Edema Treatment Market report are Retail Pharmacy, Hospital Pharmacy, Other

What are the Type segmentation covered in the Non-infectious Macular Edema Treatment Market report?

Ans: The Types covered in the Non-infectious Macular Edema Treatment Market report are Anti-VEGF Therapy, Corticosteroid, Immune Inhibitor, Biological Preparation, Other

Recommended Reports

Macular & Ophthalmic Treatment

Uveitis & Retinal Therapy

Ophthalmic Drug Market

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-infectious Macular Edema Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Anti-VEGF Therapy

1.2.3 Corticosteroid

1.2.4 Immune Inhibitor

1.2.5 Biological Preparation

1.2.6 Other

1.3 Market by Application

1.3.1 Global Non-infectious Macular Edema Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Retail Pharmacy

1.3.3 Hospital Pharmacy

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-infectious Macular Edema Treatment Market Perspective (2019-2030)

2.2 Global Non-infectious Macular Edema Treatment Growth Trends by Region

2.2.1 Non-infectious Macular Edema Treatment Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Non-infectious Macular Edema Treatment Historic Market Size by Region (2019-2024)

2.2.3 Non-infectious Macular Edema Treatment Forecasted Market Size by Region (2025-2030)

2.3 Non-infectious Macular Edema Treatment Market Dynamics

2.3.1 Non-infectious Macular Edema Treatment Industry Trends

2.3.2 Non-infectious Macular Edema Treatment Market Drivers

2.3.3 Non-infectious Macular Edema Treatment Market Challenges

2.3.4 Non-infectious Macular Edema Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Non-infectious Macular Edema Treatment by Players

3.1.1 Global Non-infectious Macular Edema Treatment Revenue by Players (2019-2024)

3.1.2 Global Non-infectious Macular Edema Treatment Revenue Market Share by Players (2019-2024)

3.2 Global Non-infectious Macular Edema Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Non-infectious Macular Edema Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Non-infectious Macular Edema Treatment Market Concentration Ratio

3.4.1 Global Non-infectious Macular Edema Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-infectious Macular Edema Treatment Revenue in 2023

3.5 Global Key Players of Non-infectious Macular Edema Treatment Head office and Area Served

3.6 Global Key Players of Non-infectious Macular Edema Treatment, Product and Application

3.7 Global Key Players of Non-infectious Macular Edema Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-infectious Macular Edema Treatment Breakdown Data by Type

4.1 Global Non-infectious Macular Edema Treatment Historic Market Size by Type (2019-2024)

4.2 Global Non-infectious Macular Edema Treatment Forecasted Market Size by Type (2025-2030)

5 Non-infectious Macular Edema Treatment Breakdown Data by Application

5.1 Global Non-infectious Macular Edema Treatment Historic Market Size by Application (2019-2024)

5.2 Global Non-infectious Macular Edema Treatment Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Non-infectious Macular Edema Treatment Market Size (2019-2030)

6.2 North America Non-infectious Macular Edema Treatment Market Size by Type

6.2.1 North America Non-infectious Macular Edema Treatment Market Size by Type (2019-2024)

6.2.2 North America Non-infectious Macular Edema Treatment Market Size by Type (2025-2030)

6.2.3 North America Non-infectious Macular Edema Treatment Market Share by Type (2019-2030)

6.3 North America Non-infectious Macular Edema Treatment Market Size by Application

6.3.1 North America Non-infectious Macular Edema Treatment Market Size by Application (2019-2024)

6.3.2 North America Non-infectious Macular Edema Treatment Market Size by Application (2025-2030)

6.3.3 North America Non-infectious Macular Edema Treatment Market Share by Application (2019-2030)

6.4 North America Non-infectious Macular Edema Treatment Market Size by Country

6.4.1 North America Non-infectious Macular Edema Treatment Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Non-infectious Macular Edema Treatment Market Size by Country (2019-2024)

6.4.3 North America Non-infectious Macular Edema Treatment Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Non-infectious Macular Edema Treatment Market Size (2019-2030)

7.2 Europe Non-infectious Macular Edema Treatment Market Size by Type

7.2.1 Europe Non-infectious Macular Edema Treatment Market Size by Type (2019-2024)

7.2.2 Europe Non-infectious Macular Edema Treatment Market Size by Type (2025-2030)

7.2.3 Europe Non-infectious Macular Edema Treatment Market Share by Type (2019-2030)

7.3 Europe Non-infectious Macular Edema Treatment Market Size by Application

7.3.1 Europe Non-infectious Macular Edema Treatment Market Size by Application (2019-2024)

7.3.2 Europe Non-infectious Macular Edema Treatment Market Size by Application (2025-2030)

7.3.3 Europe Non-infectious Macular Edema Treatment Market Share by Application (2019-2030)

7.4 Europe Non-infectious Macular Edema Treatment Market Size by Country

7.4.1 Europe Non-infectious Macular Edema Treatment Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Non-infectious Macular Edema Treatment Market Size by Country (2019-2024)

7.4.3 Europe Non-infectious Macular Edema Treatment Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Non-infectious Macular Edema Treatment Market Size (2019-2030)

8.2 China Non-infectious Macular Edema Treatment Market Size by Type

8.2.1 China Non-infectious Macular Edema Treatment Market Size by Type (2019-2024)

8.2.2 China Non-infectious Macular Edema Treatment Market Size by Type (2025-2030)

8.2.3 China Non-infectious Macular Edema Treatment Market Share by Type (2019-2030)

8.3 China Non-infectious Macular Edema Treatment Market Size by Application

8.3.1 China Non-infectious Macular Edema Treatment Market Size by Application (2019-2024)

8.3.2 China Non-infectious Macular Edema Treatment Market Size by Application (2025-2030)

8.3.3 China Non-infectious Macular Edema Treatment Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Non-infectious Macular Edema Treatment Market Size (2019-2030)

9.2 Asia Non-infectious Macular Edema Treatment Market Size by Type

9.2.1 Asia Non-infectious Macular Edema Treatment Market Size by Type (2019-2024)

9.2.2 Asia Non-infectious Macular Edema Treatment Market Size by Type (2025-2030)

9.2.3 Asia Non-infectious Macular Edema Treatment Market Share by Type (2019-2030)

9.3 Asia Non-infectious Macular Edema Treatment Market Size by Application

9.3.1 Asia Non-infectious Macular Edema Treatment Market Size by Application (2019-2024)

9.3.2 Asia Non-infectious Macular Edema Treatment Market Size by Application (2025-2030)

9.3.3 Asia Non-infectious Macular Edema Treatment Market Share by Application (2019-2030)

9.4 Asia Non-infectious Macular Edema Treatment Market Size by Region

9.4.1 Asia Non-infectious Macular Edema Treatment Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Non-infectious Macular Edema Treatment Market Size by Region (2019-2024)

9.4.3 Asia Non-infectious Macular Edema Treatment Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Size by Type

10.2.1 Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Size by Application

10.3.1 Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Size by Country

10.4.1 Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Allergan

11.1.1 Allergan Company Details

11.1.2 Allergan Business Overview

11.1.3 Allergan Non-infectious Macular Edema Treatment Introduction

11.1.4 Allergan Revenue in Non-infectious Macular Edema Treatment Business (2019-2024)

11.1.5 Allergan Recent Developments

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Non-infectious Macular Edema Treatment Introduction

11.2.4 Amgen Revenue in Non-infectious Macular Edema Treatment Business (2019-2024)

11.2.5 Amgen Recent Developments

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Non-infectious Macular Edema Treatment Introduction

11.3.4 Pfizer Revenue in Non-infectious Macular Edema Treatment Business (2019-2024)

11.3.5 Pfizer Recent Developments

11.4 Novartis AG

11.4.1 Novartis AG Company Details

11.4.2 Novartis AG Business Overview

11.4.3 Novartis AG Non-infectious Macular Edema Treatment Introduction

11.4.4 Novartis AG Revenue in Non-infectious Macular Edema Treatment Business (2019-2024)

11.4.5 Novartis AG Recent Developments

11.5 F. Hoffman-La Roche

11.5.1 F. Hoffman-La Roche Company Details

11.5.2 F. Hoffman-La Roche Business Overview

11.5.3 F. Hoffman-La Roche Non-infectious Macular Edema Treatment Introduction

11.5.4 F. Hoffman-La Roche Revenue in Non-infectious Macular Edema Treatment Business (2019-2024)

11.5.5 F. Hoffman-La Roche Recent Developments

11.6 AbbVie

11.6.1 AbbVie Company Details

11.6.2 AbbVie Business Overview

11.6.3 AbbVie Non-infectious Macular Edema Treatment Introduction

11.6.4 AbbVie Revenue in Non-infectious Macular Edema Treatment Business (2019-2024)

11.6.5 AbbVie Recent Developments

11.7 Bayer AG

11.7.1 Bayer AG Company Details

11.7.2 Bayer AG Business Overview

11.7.3 Bayer AG Non-infectious Macular Edema Treatment Introduction

11.7.4 Bayer AG Revenue in Non-infectious Macular Edema Treatment Business (2019-2024)

11.7.5 Bayer AG Recent Developments

11.8 Valeant Pharmaceuticals

11.8.1 Valeant Pharmaceuticals Company Details

11.8.2 Valeant Pharmaceuticals Business Overview

11.8.3 Valeant Pharmaceuticals Non-infectious Macular Edema Treatment Introduction

11.8.4 Valeant Pharmaceuticals Revenue in Non-infectious Macular Edema Treatment Business (2019-2024)

11.8.5 Valeant Pharmaceuticals Recent Developments

11.9 Alimera Sciences

11.9.1 Alimera Sciences Company Details

11.9.2 Alimera Sciences Business Overview

11.9.3 Alimera Sciences Non-infectious Macular Edema Treatment Introduction

11.9.4 Alimera Sciences Revenue in Non-infectious Macular Edema Treatment Business (2019-2024)

11.9.5 Alimera Sciences Recent Developments

11.10 Clearside Biomedical

11.10.1 Clearside Biomedical Company Details

11.10.2 Clearside Biomedical Business Overview

11.10.3 Clearside Biomedical Non-infectious Macular Edema Treatment Introduction

11.10.4 Clearside Biomedical Revenue in Non-infectious Macular Edema Treatment Business (2019-2024)

11.10.5 Clearside Biomedical Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Allergan plc

Amgen Inc

Pfizer Inc

Novartis

F. Hoffman-La Roche

AbbVie

Bayer

Valeant Pharmaceuticals

Alimera Sciences

Clearside Biomedical

List of Tables

Table 1. Global Non-infectious Macular Edema Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Anti-VEGF Therapy

Table 3. Key Players of Corticosteroid

Table 4. Key Players of Immune Inhibitor

Table 5. Key Players of Biological Preparation

Table 6. Key Players of Other

Table 7. Global Non-infectious Macular Edema Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 8. Global Non-infectious Macular Edema Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Non-infectious Macular Edema Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Non-infectious Macular Edema Treatment Market Share by Region (2019-2024)

Table 11. Global Non-infectious Macular Edema Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Non-infectious Macular Edema Treatment Market Share by Region (2025-2030)

Table 13. Non-infectious Macular Edema Treatment Market Trends

Table 14. Non-infectious Macular Edema Treatment Market Drivers

Table 15. Non-infectious Macular Edema Treatment Market Challenges

Table 16. Non-infectious Macular Edema Treatment Market Restraints

Table 17. Global Non-infectious Macular Edema Treatment Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Non-infectious Macular Edema Treatment Revenue Share by Players (2019-2024)

Table 19. Global Top Non-infectious Macular Edema Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-infectious Macular Edema Treatment as of 2023)

Table 20. Global Non-infectious Macular Edema Treatment Industry Ranking 2022 VS 2023 VS 2024

Table 21. Global 5 Largest Players Market Share by Non-infectious Macular Edema Treatment Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Non-infectious Macular Edema Treatment, Headquarters and Area Served

Table 23. Global Key Players of Non-infectious Macular Edema Treatment, Product and Application

Table 24. Global Key Players of Non-infectious Macular Edema Treatment, Product and Application

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Non-infectious Macular Edema Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Non-infectious Macular Edema Treatment Revenue Market Share by Type (2019-2024)

Table 28. Global Non-infectious Macular Edema Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Non-infectious Macular Edema Treatment Revenue Market Share by Type (2025-2030)

Table 30. Global Non-infectious Macular Edema Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Non-infectious Macular Edema Treatment Revenue Share by Application (2019-2024)

Table 32. Global Non-infectious Macular Edema Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Non-infectious Macular Edema Treatment Revenue Share by Application (2025-2030)

Table 34. North America Non-infectious Macular Edema Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 35. North America Non-infectious Macular Edema Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 36. North America Non-infectious Macular Edema Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 37. North America Non-infectious Macular Edema Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 38. North America Non-infectious Macular Edema Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Non-infectious Macular Edema Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Non-infectious Macular Edema Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Non-infectious Macular Edema Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 42. Europe Non-infectious Macular Edema Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 43. Europe Non-infectious Macular Edema Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 44. Europe Non-infectious Macular Edema Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 45. Europe Non-infectious Macular Edema Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Europe Non-infectious Macular Edema Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 47. Europe Non-infectious Macular Edema Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 48. China Non-infectious Macular Edema Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 49. China Non-infectious Macular Edema Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 50. China Non-infectious Macular Edema Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 51. China Non-infectious Macular Edema Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 52. Asia Non-infectious Macular Edema Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 53. Asia Non-infectious Macular Edema Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 54. Asia Non-infectious Macular Edema Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 55. Asia Non-infectious Macular Edema Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 56. Asia Non-infectious Macular Edema Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 57. Asia Non-infectious Macular Edema Treatment Market Size by Region (2019-2024) & (US$ Million)

Table 58. Asia Non-infectious Macular Edema Treatment Market Size by Region (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Size by Type (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Size by Type (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Size by Application (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Size by Application (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 64. Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Size by Country (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Size by Country (2025-2030) & (US$ Million)

Table 66. Allergan Company Details

Table 67. Allergan Business Overview

Table 68. Allergan Non-infectious Macular Edema Treatment Product

Table 69. Allergan Revenue in Non-infectious Macular Edema Treatment Business (2019-2024) & (US$ Million)

Table 70. Allergan Recent Developments

Table 71. Amgen Company Details

Table 72. Amgen Business Overview

Table 73. Amgen Non-infectious Macular Edema Treatment Product

Table 74. Amgen Revenue in Non-infectious Macular Edema Treatment Business (2019-2024) & (US$ Million)

Table 75. Amgen Recent Developments

Table 76. Pfizer Company Details

Table 77. Pfizer Business Overview

Table 78. Pfizer Non-infectious Macular Edema Treatment Product

Table 79. Pfizer Revenue in Non-infectious Macular Edema Treatment Business (2019-2024) & (US$ Million)

Table 80. Pfizer Recent Developments

Table 81. Novartis AG Company Details

Table 82. Novartis AG Business Overview

Table 83. Novartis AG Non-infectious Macular Edema Treatment Product

Table 84. Novartis AG Revenue in Non-infectious Macular Edema Treatment Business (2019-2024) & (US$ Million)

Table 85. Novartis AG Recent Developments

Table 86. F. Hoffman-La Roche Company Details

Table 87. F. Hoffman-La Roche Business Overview

Table 88. F. Hoffman-La Roche Non-infectious Macular Edema Treatment Product

Table 89. F. Hoffman-La Roche Revenue in Non-infectious Macular Edema Treatment Business (2019-2024) & (US$ Million)

Table 90. F. Hoffman-La Roche Recent Developments

Table 91. AbbVie Company Details

Table 92. AbbVie Business Overview

Table 93. AbbVie Non-infectious Macular Edema Treatment Product

Table 94. AbbVie Revenue in Non-infectious Macular Edema Treatment Business (2019-2024) & (US$ Million)

Table 95. AbbVie Recent Developments

Table 96. Bayer AG Company Details

Table 97. Bayer AG Business Overview

Table 98. Bayer AG Non-infectious Macular Edema Treatment Product

Table 99. Bayer AG Revenue in Non-infectious Macular Edema Treatment Business (2019-2024) & (US$ Million)

Table 100. Bayer AG Recent Developments

Table 101. Valeant Pharmaceuticals Company Details

Table 102. Valeant Pharmaceuticals Business Overview

Table 103. Valeant Pharmaceuticals Non-infectious Macular Edema Treatment Product

Table 104. Valeant Pharmaceuticals Revenue in Non-infectious Macular Edema Treatment Business (2019-2024) & (US$ Million)

Table 105. Valeant Pharmaceuticals Recent Developments

Table 106. Alimera Sciences Company Details

Table 107. Alimera Sciences Business Overview

Table 108. Alimera Sciences Non-infectious Macular Edema Treatment Product

Table 109. Alimera Sciences Revenue in Non-infectious Macular Edema Treatment Business (2019-2024) & (US$ Million)

Table 110. Alimera Sciences Recent Developments

Table 111. Clearside Biomedical Company Details

Table 112. Clearside Biomedical Business Overview

Table 113. Clearside Biomedical Non-infectious Macular Edema Treatment Product

Table 114. Clearside Biomedical Revenue in Non-infectious Macular Edema Treatment Business (2019-2024) & (US$ Million)

Table 115. Clearside Biomedical Recent Developments

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Non-infectious Macular Edema Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Non-infectious Macular Edema Treatment Market Share by Type: 2023 VS 2030

Figure 3. Anti-VEGF Therapy Features

Figure 4. Corticosteroid Features

Figure 5. Immune Inhibitor Features

Figure 6. Biological Preparation Features

Figure 7. Other Features

Figure 8. Global Non-infectious Macular Edema Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Non-infectious Macular Edema Treatment Market Share by Application: 2023 VS 2030

Figure 10. Retail Pharmacy Case Studies

Figure 11. Hospital Pharmacy Case Studies

Figure 12. Other Case Studies

Figure 13. Non-infectious Macular Edema Treatment Report Years Considered

Figure 14. Global Non-infectious Macular Edema Treatment Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Non-infectious Macular Edema Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Non-infectious Macular Edema Treatment Market Share by Region: 2023 VS 2030

Figure 17. Global Non-infectious Macular Edema Treatment Market Share by Players in 2023

Figure 18. Global Top Non-infectious Macular Edema Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-infectious Macular Edema Treatment as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Non-infectious Macular Edema Treatment Revenue in 2023

Figure 20. North America Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Non-infectious Macular Edema Treatment Market Share by Type (2019-2030)

Figure 22. North America Non-infectious Macular Edema Treatment Market Share by Application (2019-2030)

Figure 23. North America Non-infectious Macular Edema Treatment Market Share by Country (2019-2030)

Figure 24. United States Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Non-infectious Macular Edema Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 27. Europe Non-infectious Macular Edema Treatment Market Share by Type (2019-2030)

Figure 28. Europe Non-infectious Macular Edema Treatment Market Share by Application (2019-2030)

Figure 29. Europe Non-infectious Macular Edema Treatment Market Share by Country (2019-2030)

Figure 30. Germany Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Non-infectious Macular Edema Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 37. China Non-infectious Macular Edema Treatment Market Share by Type (2019-2030)

Figure 38. China Non-infectious Macular Edema Treatment Market Share by Application (2019-2030)

Figure 39. Asia Non-infectious Macular Edema Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 40. Asia Non-infectious Macular Edema Treatment Market Share by Type (2019-2030)

Figure 41. Asia Non-infectious Macular Edema Treatment Market Share by Application (2019-2030)

Figure 42. Asia Non-infectious Macular Edema Treatment Market Share by Region (2019-2030)

Figure 43. Japan Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Size YoY (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America Non-infectious Macular Edema Treatment Market Share by Country (2019-2030)

Figure 53. Brazil Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries Non-infectious Macular Edema Treatment Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Allergan Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2019-2024)

Figure 60. Amgen Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2019-2024)

Figure 61. Pfizer Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2019-2024)

Figure 62. Novartis AG Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2019-2024)

Figure 63. F. Hoffman-La Roche Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2019-2024)

Figure 64. AbbVie Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2019-2024)

Figure 65. Bayer AG Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2019-2024)

Figure 66. Valeant Pharmaceuticals Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2019-2024)

Figure 67. Alimera Sciences Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2019-2024)

Figure 68. Clearside Biomedical Revenue Growth Rate in Non-infectious Macular Edema Treatment Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Diabetic Macular Edema Treatment Market Research Report 2024

Global Diabetic Macular Edema Drug Market Research Report 2024

Global Non infectious Anterior Uveitis Treatment Market Research Report 2025

Ocular Inflammation Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Retinal Disorders Treatment Market Research Report 2024

Cystoid Edema Clinical Trials Market

Corneal Edema Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anal Fistula Non surgical Treatment Market Insights Forecast to 2030

Lucentis Ranibizumab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti VEGF Intravitreal Drugs Market Research Report 2024

Non surgical Vision Corrector Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non infectious Uveitis Treatment Market Research Report 2025

Global Retinal Vasculitis Treatment Market Research Report 2025

Global Ranibizumab Injection Market Research Report 2024

Global Pulmonary Edema Treatment Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions